Newswise — At the Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics (ASPET) in Orlando this week, the PhRMA Foundation announced fourteen recipients of its 2019 grants and fellowships in pharmacology/toxicology. In addition, five alumni of the PhRMA Foundation received awards from ASPET for their contributions to the field of Pharmacology and Experimental Therapeutics.

“Pharmacology, toxicology and experimental therapeutics are essential fields of endeavor in the ongoing effort to develop new treatments and cures for patients,” said PhRMA Foundation President Eileen Cannon. “The Foundation remains committed to identifying promising young scientists in these areas and providing the kind of support that will enable them to advance their research in a way that leads to significant scientific discovery.”

New pharmacology/toxicology grant recipients announced by the Foundation include:

Pre-doctoral fellowships in pharmacology/toxicology

Laura Ewing, University of Arkansas for Medical Sciences               

John Flickinger, Thomas Jefferson University                      

Timothy Krueger, John Hopkins University

Stacia Lewandowski, Drexel University College of Medicine                       

Emily Mason-Osann, Boston University       

Carmen Mitchell, Indiana University            

Courtney Smith, Yale University                   

Brittany Spitznagel, PharmD, Vanderbilt University            

Paul Wadsworth, University of Texas Medical Branch

Post-doctoral fellowships in pharmacology/toxicology

Scott D. Barnett, PhD, Medical College of Wisconsin          

Jeffery L. Dunning, PhD, Vanderbilt University

Research starter grants in pharmacology/toxicology

Adam Lauver, PhD, Michigan State University

Matthew J. Robson, PhD, University of Cincinnati

 Award in Excellence in pharmacology/toxicology

Jay Goodman, PhD, Michigan State University

The five Foundation alumni honored by ASPET all received Foundation recognition and funding for their work – a testament to the Foundation’s historical mission of providing support to launch the careers of young scientists and researchers. The Foundation is proud of their continued successes and outstanding scientific contributions.

Foundation alumni receiving awards from ASPET during the meeting included:

Namandjé N. Bumpus, PhD, Johns Hopkins University School of Medicine

Dr. Bumpus received ASPET’s 2019 John J. Abel Award in Pharmacology, recognizing her research on the impact of drug metabolites of HIV drugs on their pharmacology and toxicology and on the effect of genetic variation in drug metabolism on anti-HIV drug disposition. She received two PhRMA Foundation awards to support her research efforts in Pharmacology/Toxicology earlier in her career.

Nariman Balenga, PhD, University of Maryland School of Medicine

The ASPET Division for Translational and Clinical Pharmacology named Dr. Balenga the recipient of its 2019 Early Career Award in recognition of excellence in translational and clinical pharmacology research as an early career scientist. He received a PhRMA Foundation 2016 Research Starter Grant in Translational Medicine in Therapeutics.

Michelle Mazei-Robison, PhD, Michigan State University

The ASPET Division for Neuropharmacology named Dr. Mazei-Robison the recipient of its 2019 Division for Neuropharmacology Early Career Award, honoring a young independent investigator working in neuropharmacology. Dr. Mazei-Robison received a PhRMA Foundation 2014 Research Starter Grant in Pharmacology/Toxicology.

Raymond M. Quock, PhD, Washington State University

Dr. Quock received ASPET’s 2019 E. Leong Way Emeritus Travel Award. This award provides financial support to defray the expenses for an ASPET emeritus member to attend the ASPET Annual Meeting. Dr. Quock received a PhRMA Foundation Research Starter Grant in Pharmacology/Toxicology in 1976.

Gary O. Rankin, PhD, Joan C. Edwards School of Medicine at Marshall University

The ASPET Division for Toxicology named Dr. Rankin the recipient of the division’s 2019 Toxicology Career Award, recognizing outstanding original research contributions to toxicology by an established investigator. Dr. Rankin received a PhRMA Foundation Research Starter Grant in Pharmacology/Toxicology in 1979. He is also a dedicated advisory committee member of the Foundation.

 

About the PhRMA Foundation

For more than 50 years, the PhRMA Foundation has been helping to build a larger pool of highly-trained, top-quality scientists to meet the growing needs of scientific and academic institutions, government, and the research-intensive pharmaceutical industry. To advance this mission, the PhRMA Foundation has awarded more than $90 million in competitive research fellowships and grants since its founding. The Foundation’s emphasis on evidence-based research that determines the true value of medicines is supported by its Value Assessment Initiative.  To date, the Foundation has awarded more than $2.8 million to support a variety of research projects to help advance this goal, including the establishment of four national Centers of Excellence in Value Assessment.

To learn more, please visit www.phrmafoundation.org

MEDIA CONTACT
Register for reporter access to contact details